Cervical Cancer Risk Doubles with Longer Screening Intervals

MARCH 01, 2003
A woman?s relative risk of invasive cervical cancer doubles if she is screened at 2- or 3-year intervals after her last negative cervical smear, rather than at 1-year intervals, according to a case-control study published recently in Obstetrics and Gynecology. No significant difference was found between a 2- or a 3-year screening interval. Although a woman?s absolute risk for developing cervical cancer remains low, the researchers noted that these findings are important for policymakers to consider when evaluating the costs and impact of a decrease in screening frequency. The findings are based on data from 1466 women in the Kaiser Permanente health maintenance organization in northern California.

SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.